Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value:
$179.89M
Total Bought:
$119.81M
Total Sold:
$123.13M
Net Transaction:
-$3.32M
Notable People:
Slanix Paul T Alex
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Blueprint Medicines Corp0160,950+160,950$0$15.27M8.49%+$15.27M
Soleno Therapeutics Inc309,950336,486+26,536$12.48M$14.40M8.01%+$1.93M
CG Oncology, Inc.(CGON)0320,378+320,378$0$14.06M7.82%+$14.06M
Xenon Pharmaceuticals Inc.(XENE)241,961309,369+67,408$11.14M$13.32M7.40%+$2.17M
Verona Pharma PlcADS0736,738+736,738$0$11.85M6.59%+$11.85M
Merus N V274,923255,928-18,995$7.56M$11.52M6.41%+$3.96M
Praxis Precision Medicines, Inc.(PRAX)70,424159,486+89,062$1.57M$9.73M5.41%+$8.16M
Mind Medicine Mindmed Inc01,001,452+1,001,452$0$9.41M5.23%+$9.41M
Avadel Pharmaceuticals PlcADR347,036547,036+200,000$4.90M$9.24M5.14%+$4.34M
Geron Corporation(GERN)2,971,6392,760,497-211,142$6.27M$9.11M5.06%+$2.84M
Jasper Therapeutics, Inc.(JSPR)0289,943+289,943$0$8.51M4.73%+$8.51M
Kura Oncology, Inc.(KURA)0365,044+365,044$0$7.79M4.33%+$7.79M
Insmed Incorporated(INSM)0250,000+250,000$0$6.78M3.77%+$6.78M
Dianthus Therapeutics, Inc.(DNTH)0216,968+216,968$0$6.51M3.62%+$6.51M
Olema Pharmaceuticals, Inc.(OLMA)659,035559,035-100,000$9.25M$6.33M3.52%-$2.92M
Lyra Therapeutics Inc01,003,741+1,003,741$0$6.24M3.47%+$6.24M
Longboard Pharmaceuticals In0270,559+270,559$0$5.84M3.25%+$5.84M
Rapt Therapeutics Inc0420,000+420,000$0$3.77M2.10%+$3.77M
Mersana Therapeutics Inc0801,437+801,437$0$3.59M2.00%+$3.59M
Marinus Pharmaceuticals Inc0394,773+394,773$0$3.57M1.98%+$3.57M
Promis Neurosciences Inc1,066,6741,059,582-7,092$1.23M$2.02M1.13%+$797.1K
Context Therapeutics Inc.(CNTX)725,951725,9510$820.3K$1.00M0.56%+$181.5K
Alpine Immune Sciences Inc357,2710-357,271$6.81M$0—-$6.81M
Amylyx Pharmaceuticals, Inc.(AMLX)275,7730-275,773$4.06M$0—-$4.06M
Apellis Pharmaceuticals Inc
COM
150,0000-150,000$8.98M$0—-$8.98M
argenx SEADR(ARGX)35,0000-35,000$13.32M$0—-$13.32M
Axsome Therapeutics, Inc.(AXSM)100,8620-100,862$8.03M$0—-$8.03M
Compass Therapeutics, Inc.(CMPX)834,6300-834,630$1.30M$0—-$1.30M
Cymabay Therapeutics Inc489,9380-489,938$11.57M$0—-$11.57M
Harpoon Therapeutics Inc428,4000-428,400$4.87M$0—-$4.87M
Intra-Cellular Therapies Inc141,3480-141,348$10.12M$0—-$10.12M
Jasper Therapeutics, Inc.(JSPR)3,659,2550-3,659,255$28.87M$0—-$28.87M
Medavail Holdings Inc117,8970-117,897$529.4K$0—-$529.4K
MoonLake ImmunotherapeuticsCL A(MLTX)143,4790-143,479$8.66M$0—-$8.66M
Ambrx Biopharma Inc385,3830-385,383$5.49M$0—-$5.49M
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q1 2024 | TickerTrail